SunHo BioPharmaceutical Co., Ltd.a clinical-stage leading biopharmaceutical company in immunocytokines with full-set of capabilities from discovery to commercialization, announced

MaaT Pharma, a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM dedicated to improving survival outcomes for patients

Riparian Pharmaceuticals, a Viva Biotech portfolio company, is a biotechnology company focused on discovering novel therapeutics for cardiovascular diseases. Riparian today announced it has entered into an exclusive license agreement and research agreement with Pfizer.

Approved for Public Release, Distribution Unlimited — The Defense Advanced Research Projects Agency (DARPA) announced that Ginkgo Bioworks which is building

Gannex Pharma Co., Ltd. a wholly-owned company of Ascletis Pharma Inc.announces today the completion of enrollment of 98 patients with primary biliary cholangitis

Santen Pharmaceutical Co.,Ltd.announced today that it has signed licensing agreements and an asset transfer agreement with two U.S. companies.

Endo International plc announced today that its Par Sterile Products business has begun shipping bivalirudin injection in a ready-to-use 250 mg/50 mL single-use vial. It is the only ready-to-use liquid format of bivalirudin on the market in the U.S.

Umitomo Chemical Co., Ltd, one of Japan's leading chemical companies, and Ginkgo Bioworks which is building the leading platform for cell programming and biosecurity,

Beckman Coulter Diagnostics, a leader in clinical diagnostics, and Fujirebio, a leader in neurological markers and in vitro diagnostics, announced today the formation of a new

Scipher Medicine today announced that it has entered into a multi-disease area collaboration with Ionis Pharmaceuticals. In the collaboration, Ionis is responsible